Strategy View

Key points:

 

  • The deceleration of median sales and earnings growth for S&P 500 companies abated, as growth equaled that of Q2.
  • Sales growth of 4% and EPS growth of 6% matched the lowest totals since Q2 2016 and Q1 2016, respectively.
  • Versus an EPS bar that was lowered significantly coming into the quarter, companies beat by a median of 3%, which has been typical of the past several years.
  • Health Care was the clear large-cap standout, with best growth and beats and an acceleration in growth from Q2. Tech, Staples, and Cyclical were among the weakest.
  • On valuation, a much lower 10-year yield supports higher stock valuations, and as long as earnings remain positive, the market should move higher. However, Q4 earnings estimates are still being lowered, notably for small caps, meaning we are not at a clear bottom yet.
  • Similar to the corrections of 2011–2012 and 2015–2016, sector rotation has favored small-cap, value, cyclical, and industrial initially (and coincided with ~1.5% 10-year yield).
    • Because of this our Focus List count has not increased much since October’s bottom. This should change if the rally persists and/or accelerates.

Strategy View

Key Points:

  • A very strong first 10 months of the year has led to better-than-average returns in November/December.
    • Since 1900, in 33 years when the DJIA has gained 15%+ in the first 10 months of the year, November averages a 2.7% gain and December averages a 2.2% gain. This is much better than the November and December averages of 0.4% and 0.8%, respectively, in all other years.
  • A very strong annual gain, however, does not lead to better or worse average returns the following year.
    • Since 1900, in 34 years of a 20% DJIA annual gain, the following year averages a 7% gain, versus an 8% gain for all other years.
  • The current market leg on the DJIA of 8% is still well below the bull market average up leg of 14% and median of 11%.
  • The current shift of styles to value outperformance is similar to the conclusion of the 2011–2012 and 2015–2016 corrections. In those cases, it persisted for 2–3 quarters before fading.

Global Breakouts

Global Breakouts Update

An above-average number of stocks making new 52-week, multi-year, or all-time
highs is typically an indicator of a strong market. We think an even better measure is
the number of stocks breaking out of consolidations. To be counted in this measure,
each stock will need to have built some sort of base, or pattern (flat, cup, double
bottom, etc.), before breaking past the left-side highs of that pattern, and into relative
highs.

Strategy View

Key points:

 

  • We note the relative strength improvement of U.S value, small-cap, developed, emerging, APAC, and EMEA ETFs in the short run, but are also wary of the potential for another head-fake, similar to in June/July.
  • A weaker USD in relation to the international ETF, and a stronger economy in relation to all of the above, will likely be necessary to sustain the moves, and for us to recommend overweighting these areas (versus benchmark of large U.S. growth).
  • On breakouts, we have seen a pickup in the U.S. and developed markets to above average, but are still waiting on a large spike which could be a true turning point. Emerging continues to lack a high number of breakouts.
  • In the short run, areas working best are cheap U.S. Financials, Cyclicals, Semis, Discretionary, and Industrials; Developed Industrials, Health Care ( HK ), and Cyclicals; Emerging Financials and Tech; and China Health Care and Staple.
    • U.S. overlap in the above spaces include VIAV, KEYS, CHDN, LULU.
    • Developed overlap include SMSC.JP (2175 JP), VIVB.HK (1873 HK), SAXX.DE (SAX GR), YHEC.HK (1558 HK).
    • Emerging overlap include CLI.TW (5871 TT), BMF.BR (B3SA3 BZ), KYX.KR (098460 KS), IEI.IN ( INFOE IN ), and DAB.IN ( DABUR IN ).

Strategy View

Key Points:

  • Median 4% sales and 3% EPS growth expected for S&P 500. 3% sales and -2% EPS for S&P 600.
    • Fourth quarter of median earnings deceleration for the S&P 500 expected. Sales expected flat from last two quarters, which matches lowest in seven quarters.
  • Notably, the trend of lower estimates has been happening for several quarters and is not abating. Since May, S&P 500 Q3/Q4 2019 and Q1/Q2 2020 estimates have all come down substantially. This is true even after a 3% earnings beat in Q2. But, full-year 2020 numbers (black line) have not come down much. This likely means a further revision lower is necessary.

Strategy View

Key Points:

Technically, the overall commodity complex remains very weak. The Invesco DB Commodity Index is nearly 20% off 52-week highs, well below both the 10- and 40-WMA. In addition, it has undercut the May lows suggesting further downside risk. There is support at the December 2018 lows. A retest of that level is possible as most commodities outside of precious metals ( majority of index weighting ) are trending lower.

Marked divergence within the space, as commodities related to agricultural consumption and most related to industrial production are very weak, while precious metals are trending higher.

We will be watching for some consolidation near highs in the leading precious metal groups and, conversely, weak bounces from lows in the other lagging commodity groups for new opportunities to play the inverse trends.

See attachment for stocks of interest in both best and worst groups.

Strategy View

Key Points:

 

  • Median Q2 S&P 500 earnings grew 6% y/y while revenues rose 4%. EPS beat by 3%.
    • Health Care had the best quarter, with 6% revenue and 12% EPS growth, and among the best beats for both.
    • Material and Cyclical were weak, with below average revenue growth and almost no earnings growth.
  • Median y/y Q2 S&P 600 EPS grew just 2% y/y, even with a 4% upside surprise, while revenues rose 4%.
    • Staple and Technology had the best quarters, well above overall median EPS growth.
    • Cyclical and Financial were weak, with -4% and 0% EPS growth, respectively.
  • Forward estimates continue to fall. Median Q3 S&P 500 earnings are expected to grow 3%, down 1.2% from 90 days ago. Median Q3 S&P 600 earnings are expected to be flat, down 4% from 90 days ago.
  • 2020 EPS estimates are probably too high, but as long as we do not slip into an earnings recession, we remain hopeful of the bull’s continuation.
  • Indices are just below their 50-DMA, and nine of 11 sectors remain below that level as well. We remain in an Uptrend Under Pressure until this improves.
  • We have 58 USFL names, still above the long-term average of 50. However, only a few are currently actionable.
    • American Tower ( AMT ), Applied Materials ( AMAT ), Ceridian ( CDAY ), Fleetcor ( FLT ), Hubspot ( HUBS ), Interxion ( INXN ), Keysight ( KEYS ), Motorola ( MSI ), and Twitter ( TWTR ).

Strategy View

Key Points:

S&P 500 gain of 4% and NDQC gain of 6% since the follow-through day (six weeks) compare favorably to historical gains after a correction (overall median is 3% after four weeks and 5% after eight weeks).

Looking at examples where the S&P 500 was up more than 3% after four weeks, we see it leads to better-than-normal 13-week performance. 

In nine instances, the median 13-week gain is 7%, versus a median gain of 4% for the other nine.

Sector-wise, expect more divergence from here. In those nine instances, the 13-week sector spread from best-to-worst averages +20%. Currently, it is only at 5%.

Long-term outperforming sectors like Retail, Health Care, and Staple have historically started better after a follow-through day but trailed off after the first eight weeks. Cyclical and commodity sectors have finished the strongest over the last five weeks.

Strategy View

Key Points:

S&P 500 Earnings

Expected to decelerate to 4% median earnings growth. Sales expected to be flat from Q1 at 4%. This would tie with Q1 2019 for the slowest sales growth since Q4 2016 and would be the slowest earnings growth since Q1 2016.

However, we expect a normal beat of 3-4%. The bigger key will be to see if the trend in downward revisions after earnings comes to an end. Forward earnings have been consistently revised lower since September 2018.

Into the beginning of the season, the VIX is low, at 13, and investor advisors are skewed bullish, at 53%, although not extreme (60%+).

Given a falling 10-year bond yield (historically inverse relationship with market P/E ratio), the market multiple should expand. Unless forward earnings are much worse than expected, this could fuel a push further into all-time highs.

Index/Sector/Stock Trends

Major indices are at or within 1% of all-time highs, as are six of 11 sectors (Utility, Staple, Retail, Financial, Tech, Cap Equip).

Growth stocks are acting well. Our Focus List count of 63 is well above the long-term average of 50.

There are however, more extended names than actionable names on our Focus List. The most extended are COUP, VEEV, CYBR, TEAM, PLNT, NOW, GLOB, and EEFT.

The actionable list includes AMD, COLD, EW, VIAV, DIS, and ILMN.

Global Markets Overview

Key points:

 

  • Global Index is consolidating. VT ETF is in the middle of two-month range after a ‘normal’ pullback. Retake of 50-DMA this week.
  • Market conditions skewed positive, 50-50 market direction indicator turned positive two weeks ago, now above 75%. Generally higher conviction at 70%+.
  • While the U.S. and mostly other small markets ( Australia/N.Z., Greece, Poland, Russia ) were the leaders through last week, we had several major upgrades this week. On the DM side, follow-through days in the U.K., Japan, Hong Kong, among several others; and on the EM side, follow-through days​​​​​​​ in Brazil and Taiwan.
  • U.S. market with a typical pullback after a larger-than-normal leg higher through April.
    • Follow-through day in early June – likelihood of success? Three potential scenarios.
  • U.S. market yield curve history and market seasonality ( weak ), versus favorable setup given first half gains.
  • Number of U.S. Focus List stocks back above long-term average.
  • Number of weekly breakouts in the U.S., developed, and emerging all back to normal levels.
  • Global themes with most breadth in leadership:
    • U.S.: payments/financial services, software, med-tech, aerospace/defense
    • Developed ex-U.S.: chemicals, financial services, food/beverages, med-tech
    • Emerging ex-China: banks, consumer loans, real estate development, telecom, apparel/consumer
    • China: banks, food/food service/alcohol, medical service
    • Frontier: banks, telecom, cement, retail